Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG38112

ITPKA Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The ITPKA Knockout HEK293T Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal knockout population targeting ITPKA in HEK293T cells. ITPKA controls calcium signaling and actin cytoskeleton reorganization by phosphorylating IP3 to IP4 and directly binding F-actin, with interactions involving calmodulin and 14-3-3??. This model enables investigation of calcium dynamics, actin bundling, and cell migration in an easily transfectable epithelial host. Applications include cancer metastasis research, neurodegenerative disease studies, and functional interrogation of inositol phosphate metabolism and cytoskeletal regulation.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    ITPKA

    Gene Identifier

    NCBI Gene ID 3706

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The ITPKA Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population targeting the ITPKA gene. This heterogeneous pool provides a loss-of-function model for studying inositol-trisphosphate 3-kinase A (ITPKA) functions without clonal selection. The polyclonal format captures diverse editing events, making it ideal for population-level signaling and functional genomics studies.

The parental HEK293T cell line is a human embryonic kidney epithelial derivative that stably expresses SV40 large T-antigen, enabling episomal replication of plasmids with an SV40 origin. This feature supports high-efficiency transient transfection and viral packaging, establishing HEK293T as a versatile tool in molecular biology for protein expression, lentiviral production, and biochemical assays.

ITPKA is a key regulator of inositol phosphate signaling and actin dynamics. It phosphorylates IP3 to IP4, dampening IP3-mediated calcium release from intracellular stores. ITPKA is activated by GPCR/PLC signaling and CaMKII, and it interacts with calmodulin, F-actin, 14-3-3??, and the IP3 receptor. Beyond catalysis, ITPKA directly bundles F-actin, influencing actin filament organization and cell migration through cofilin pathways. Thus, ITPKA integrates calcium and cytoskeletal signaling.

In HEK293T cells, ITPKA knockout permits dissection of its dual roles in calcium flux and actin remodeling. Despite their epithelial origin, HEK293T cells display actin-driven processes and respond to GPCR agonists, making them a useful model for studying migration-related mechanisms. Loss of ITPKA enables examination of how disrupted IP3 metabolism and actin bundling alter cellular responses to stimuli, with relevance to cancer metastasis and neuronal development.

This knockout pool supports diverse assays: western blotting and RT-qPCR for gene expression validation; calcium imaging for altered signaling dynamics; phalloidin staining for actin cytoskeleton visualization; and migration/invasion assays to assess phenotypic effects. Co-immunoprecipitation and phospho-signaling analysis map interaction networks. RNA-seq may reveal transcriptomic changes. For additional information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)